Ocugen has received approval from the DSMB to begin dosing the second cohort of patients in a trial of OCU200 for diabetic ...

Fitzpatrick skin type influences both characteristics and outcomes associated with uveal melanoma and conjunctival melanoma.

Turnstone Biologics (NASDAQ:TSBX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect Turnstone Biologics to post ...

One of the hardest lessons learned occurred after I inadvertently failed at communication and education before transferring a ...

Reports Q4 revenue $15.1M, consensus $14.96M. “In 2024, the successful launch of HEPZATO drove strong financial and operational results, ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial ...

As many as half of people diagnosed with uveal melanoma (ocular melanoma) go on to have what’s called metastatic disease. Most often, the cancer metastasizes (spreads) beyond the eye to the ...

Delcath Systems (NASDAQ:DCTH) is scheduled to announce Q4 earnings results on Thursday, March 6th, before market open. The consensus EPS Estimate is $0.01 (+102.1% Y/Y) and the consensus Revenue ...

ABSTRACT: The rapid development of artificial intelligence (AI) technology is profoundly reshaping all walks of life, especially in the medical field. AI provides innovative tools for medical ...

The Uveal Melanoma market reached a value of USD 1,000 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,600 Million by 2035, exhibiting a growth rate (CAGR) of 4.28% during ...